Concepedia

Publication | Open Access

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders†‡

DOIFull Paper Access

23

Citations

14

References

2009

Year

Vinod K. Rustgi, William M. Lee, Eric Lawitz, Stuart C. Gordon, Nezam H. Afdhal, Fred Poordad, Herbert L. Bonkovsky, Leif Bengtsson, Gurudatt Chandorkar, Matthew Harding,
Hepatology

Abstract

The addition of MMPD to Peg-IFN-alfa-2a and RBV combination therapy did not increase the proportion of nonresponder patients with genotype 1 CHC achieving an SVR.

References

YearCitations

Page 1